Skip to search formSkip to main contentSkip to account menu

6059-S

Known as: 6059 S, S-6059, 6059S 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Manipulating the N release from high-N crop residues by simultaneous mixing of these residues with organic biological waste (OBW… 
1981
1981
1. MIC of 6059-S against 92 strains of clinically isolated bacteria were measured. The compound was active against most of Gram… 
1981
1981
Experimental and clinical studies in the pediatric field on 6059-S, a newly synthesized broad spectrum parenteral antibiotics… 
1981
1981
The effect of 6059-S, a novel 1-oxacephem, on peptidoglycan synthesis was investigated using ether-treated cells of Escherichia… 
1981
1981
Laboratory and clinical studies were performed on 6059-S in the field of pediatrics, a new semi-synthetic 1-oxacephem antibiotic… 
1981
1981
6059-S, a new injectable oxacephem antibiotic, has been investigated to give following results. 1. Clinical results Twenty… 
Highly Cited
1980
Highly Cited
1980
Moxalactam (6059-S) {7β-[2-carboxy-2-(4-hydroxyphenyl)acetamido]-7α-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]-methyl]-1-oxa-1… 
1980
1980
Moxalactam (6059-S) is a new beta-lactam derivative with a structure markedly different from those of penicillins or…